Literature DB >> 870009

Management of hyperprolactinaemic amenorrhoea.

S Franks, H S Jacobs, M G Hull, S J Steele, J D Nabarro.   

Abstract

Results of treatment of 52 patients with amenorrhoea associated with hyperprolactinaemia are presented. All patients had a detailed radiological examination of the pituitary fossa, including lateral tomography in every patient and air encephalography in those in whom a pituitary tumour was suspected. There were 17 patients with untreated pituitary tumours, 5 patients with previously treated pituitary tumours and persisting hyperprolactinaemia, and 30 patients with normal pituitary radiology. Patients with pituitary tumours were treated either by transsphenoidal or transfrontal surgical extirpation of the tumour, followed, if necessary, by external irradiation and/or bromocriptine, Four patients were treated with external irradiation as primary therapy, and three patients who did not wish to conceive were treated with bromocriptine as primary therapy. Patients with normal radiological appearances were treated with bromocriptine as primary treatment. Ovulatory menstrual cycles developed in 42 patients and there were 19 pregnancies. Those ovulating but not conceiving had adequate nonendocrine factors to account for the disparity. Failure of response was seen in 10 patients and was due to inadequate fall of prolactin in response to surgery (2 patients), external irradiation (3 patients) and bromocriptine (1 patient), and gonadotrophin deficiency which developed after surgery in 3 patients but was present pre-operatively in 1. The relative merits of treatment by surgery, external irradiation and bromocriptine are discussed and a policy of treatment outlined.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870009     DOI: 10.1111/j.1471-0528.1977.tb12571.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  11 in total

1.  Pituitary tumours and pregnancy.

Authors:  K W Hancock; J S Scott; R M Gibson; J T Lamb
Journal:  Br Med J       Date:  1978-06-03

2.  Bromocriptine treatment of macroprolactinomas: studies on the time course of tumor shrinkage and morphology.

Authors:  M Nissim; B Ambrosi; V Bernasconi; G Giannattasio; M A Giovanelli; M Bassetti; U Vaccari; P Moriondo; A Spada; P Travaglini; G Faglia
Journal:  J Endocrinol Invest       Date:  1982 Nov-Dec       Impact factor: 4.256

3.  [Hyperprolactinemia and sterility].

Authors:  H K Rjosk; R Fahlbusch; K von Werder
Journal:  Arch Gynecol       Date:  1979-07-20

Review 4.  Pharmacology of bromocriptine in health and disease.

Authors:  A E Mehta; G Tolis
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

5.  Outcome of pregnancy in mothers given bromocriptine.

Authors:  R W Griffith; I Turkalj; P Braun
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

Review 6.  Use of bromocriptine in hyperprolactinaemic anovulation and related disorders.

Authors:  S Franks
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

7.  Bromocriptine in pregnancy: safety aspects.

Authors:  P Krupp; C Monka
Journal:  Klin Wochenschr       Date:  1987-09-01

8.  Effectiveness of pergolide mesylate in long term treatment of hyperprolactinaemia.

Authors:  S Franks; P M Horrocks; S S Lynch; W R Butt; D R London
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-09

9.  Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumors.

Authors:  T Bergh; S J Nillius; L Wide
Journal:  Br Med J       Date:  1978-04-08

10.  Pregnancy in patients presenting with hyperprolactinaemia.

Authors:  M O Thorner; C R Edwards; M Charlesworth; J E Dacie; P J Moult; L H Rees; A E Jones; G M Besser
Journal:  Br Med J       Date:  1979-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.